Filament Health Corp. reports Q2 results

2 hours ago 1

Filament Health Corp. press release (NEOE:FH:CA): Q2 On April 9, 2025, the Company closed a financing of $961,275 further to the issuance of units, comprised of a secured convertible debenture of the company and a warrant.
Cash and cash equivalents of $679,972;
Cash used in operating activities of $592,136; and total revenues of $259,013.

Recommended For You